A Registry of COPD Patients to be Used for Future Studies

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Ohio State University
Information provided by (Responsible Party):
Philip Diaz, The Ohio State University
ClinicalTrials.gov Identifier:
First received: December 23, 2008
Last updated: April 20, 2015
Last verified: April 2015
To develop a cohort of COPD participants to assist study staff in determining the most likely candidates for future studies.

Chronic Obstructive Lung Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Ohio State University COPD Registry

Resource links provided by NLM:

Further study details as provided by Ohio State University:

Primary Outcome Measures:
  • This is a registry protocol to determine factors contributing to the development of chronic obstructive lung disease. [ Time Frame: unknown ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To develop a repository of blood from subjects with COPD for future studies. These studies may include evaluation of biologic markers of disease severity and progression. [ Time Frame: unknown ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA
whole blood

Estimated Enrollment: 600
Study Start Date: December 2008
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Chronic obstructive lung disease
those with a condition

Detailed Description:
To develop a cohort of COPD participants for study staff to determine the most likely candidates for future studies and to develop a repository of blood from subjects with COPD for future studies.

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
primary care clinic

Inclusion Criteria:

  • Patients who are 18 years of age and older who have been diagnosed with COPD by at least one of the following:

    • clinical history-a documented history of COPD, emphysema, or chronic bronchitis;
    • pulmonary function results (defined as an FEV1/FVC less than 0.7;
    • radiographic results (high-resolution CT findings of emphysema

Exclusion Criteria:

  • in ability to give informed consent
  • prisoners
  • pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00814203

Contact: Janice E Drake, CRTT 614-366-2287 janice.drake@osumc.edu
Contact: Sharon T Cheung, BS 614-366-2258 sharon.cheung@osumc.edu

United States, Ohio
The Ohio State University Recruiting
Columbus, Ohio, United States, 43210
Principal Investigator: Philip T Diaz, MD         
Sub-Investigator: Michael E Ezzie, MD         
Sub-Investigator: Clay B Marsh, MD         
Sponsors and Collaborators
Philip Diaz
Principal Investigator: Philip Diaz, MD Ohio State University
  More Information

Responsible Party: Philip Diaz, Philip Diaz M.D., The Ohio State University
ClinicalTrials.gov Identifier: NCT00814203     History of Changes
Other Study ID Numbers: 2007H0248 
Study First Received: December 23, 2008
Last Updated: April 20, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by Ohio State University:

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 26, 2016